Related references
Note: Only part of the references are listed.Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation
Kim Newton
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease
Amine Majdi et al.
JOURNAL OF HEPATOLOGY (2020)
Peroxisome proliferator-activated receptor gamma (PPARγ) activation and metabolism disturbance induced by bisphenol A and its replacement analog bisphenol S using in vitro macrophages and in vivo mouse models
Pingshi Gao et al.
ENVIRONMENT INTERNATIONAL (2020)
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
Najoua Lalaoui et al.
NATURE (2020)
A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
Panfeng Tao et al.
NATURE (2020)
Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
Shelbi Christgen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
PANoptosis components, regulation, and implications
R.K. Subbarao Malireddi et al.
Aging-US (2020)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Targeting RIPK1 for the treatment of human diseases
Alexei Degterev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Post-translational modification of the death receptor complex as a potential therapeutic target in cancer
Kidong Kang et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell et al.
HEPATOLOGY (2019)
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Junying Yuan et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
Yue Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
RIP Kinases in Liver Cell Death, Inflammation and Cancer
Vangelis Kondylis et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel et al.
HEPATOLOGY (2018)
Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature
Fahrettin Haczeyni et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Apoptosis and non-alcoholic fatty liver diseases
Tatsuo Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The kinase receptor-interacting protein 1 is required for inflammasome activation induced by endoplasmic reticulum stress
Liang Tao et al.
CELL DEATH & DISEASE (2018)
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Daichao Xu et al.
CELL (2018)
Apoptosis and necroptosis in the liver: a matter of life and death
Robert F. Schwabe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
David Goldberg et al.
GASTROENTEROLOGY (2017)
Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis
Trieu-My Van et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
Yannick Boege et al.
CANCER CELL (2017)
RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient mice
Yongbo Liu et al.
CELL DEATH AND DIFFERENTIATION (2017)
Liver macrophages in tissue homeostasis and disease
Oliver Krenkel et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Cynthia Ju et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Receptor interacting protein 3 protects mice from high-fat diet-induced liverinjury
Sanjoy Roychowdhury et al.
HEPATOLOGY (2016)
The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis
Claudia Guenther et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
RIPK1 protects from TNF-α-mediated liver damage during hepatitis
Aveline Filliol et al.
CELL DEATH & DISEASE (2016)
Questions and controversies: the role of necroptosis in liver disease
Lily Dara et al.
CELL DEATH DISCOVERY (2016)
Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease
Itziar Frades et al.
PLOS ONE (2015)
RIPK1 and RIPK3: critical regulators of inflammation and cell death
Kim Newton
TRENDS IN CELL BIOLOGY (2015)
Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes
Wasco Wruck et al.
SCIENTIFIC DATA (2015)
Control of Life-or-Death Decisions by RIP1 Kinase
Dana E. Christofferson et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Jeremie Gautheron et al.
EMBO MOLECULAR MEDICINE (2014)
Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
Scott B. Berger et al.
JOURNAL OF IMMUNOLOGY (2014)
RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway
Xiaqiong Wang et al.
NATURE IMMUNOLOGY (2014)
Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death
Dan Weng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice
Jean-Philippe Pradere et al.
HEPATOLOGY (2013)
Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
Dimitry Ofengeim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
The NLRP12 Inflammasome Recognizes Yersinia pestis
Gregory I. Vladimer et al.
IMMUNITY (2012)
Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
Yuki Kita et al.
PLOS ONE (2012)
Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis
Julia Starmann et al.
PLOS ONE (2012)
Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis
Puneet Puri et al.
HEPATOLOGY (2009)
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
Anna Wieckowska et al.
HEPATOLOGY (2006)
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
IT De Almeida et al.
CLINICAL NUTRITION (2002)